In vitro and in vivo characterisation of nor-β-CIT: A potential radioligand for visualisation of the serotonin transporter in the brain

European Journal of Nuclear Medicine

Volumn 24, Issue 6, 1997, Pages 596-601

  Bergström, Kim A ^a,b   Halldin, Christer ^a   Hall, Håkan ^a   Lundkvist, Camilla ^a   Ginovart, Nathalie ^a   Swahn, Carl Gunnar ^a   Farde, Lars ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

2 carbomethoxy 3 (4 iodophenyl)nortropane; Autoradiography; Brain; Positron emission tomography; Serotonin transporter

Indexed keywords

3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; CARBON 11; DOPAMINE TRANSPORTER; IODINE 125; RADIOLIGAND; RADIOPHARMACEUTICAL AGENT; SEROTONIN;

ANIMAL EXPERIMENT; ARTICLE; AUTORADIOGRAPHY; BRAIN; BRAIN CORTEX; BRAIN TOMOGRAPHY; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; HUMAN; HUMAN TISSUE; MALE; MONKEY; NEOCORTEX; NONHUMAN; PHOTON EMISSION TOMOGRAPHY; THALAMUS;

ANIMALS; AUTORADIOGRAPHY; BRAIN; CARBON RADIOISOTOPES; CARRIER PROTEINS; COCAINE; HUMANS; IODINE RADIOISOTOPES; MACACA FASCICULARIS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; RADIOLIGAND ASSAY; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; THALAMUS; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

PARTICLE BEAMS; POSITRON EMISSION TOMOGRAPHY; POSITRONS; RADIOACTIVITY; RADIOGRAPHY;

2Β-CARBOMETHOXY-3Β-(4-IODOPHENYL)NORTROPANE; 4-IODOPHENYL; AUTORADIOGRAPHY; HUMAN BRAIN; IN-VITRO; RADIOLIGANDS; SEROTONIN TRANSPORTERS; STRIATUM; VITRO AND IN VIVO; Β-CIT;

BRAIN;

EID: 0030764452     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050092     Document Type: Article

References (46)

1. Rickels K, Schweizer E, Clinical overview of serotonin reuptake inhibitors. J Clin Psychiatry 1990; 51: 9-12.
2. 3H-imipramine binding sites in control and Parkinsonian brain. Eur J Pharmacol 1985; 117: 71-80.
3. Palmer AM, Francis PT, Benton JS, et al. Presynaptic serotonergic dysfunction in patients with Alzheimer's disease. J Neurochem 1987; 48: 8-15.
4. Battaglia G, Yeh SY, O'Hearn E, Molliver ME, Kuhar MJ, DeSouza EB. MDMA effects in the brain: pharmacological profile and evidence of neurotoxicity from neurochemical and autoradiographic studies. J Pharmacol Exp Ther 1987; 241: 911-916.
5. Ricaurte GA, Molliver ME, Martello MB, Katz JL, Wilson MA, Martello AL. Dexfenfluramine neurotoxicity in brains of non-human primates. Lancet 1990; 338: 1487-1488.
6. 123I]2β-carbomethoxy-3β-(4-iodophenyl)tropane: high-affinity SPECT radiotracer of monoamine reuptake sites in brain. J Med Chem 1991; 34: 3144-3146.
7. 123I]β-CIT) in human brain. Eur J Nucl Med 1993; 20:783-786.
8. 123I]β-CIT. Binding kinetics in the human brain. J Neural Transm Gen Sect 1993; 94: 137-146.
9. Innis RB, Seibyl JB, Wallace E et al. SPECT imaging demonstrates loss of striatal dopamine transporters in Parkinson's disease. Proc Natl Acad Sci USA 1993; 90: 11965-11969.
10. 11C]β-CIT, a cocaine analogue. Preparation, autoradiography and preliminary PET investigations. Nucl Med Biol 1993; 20: 249-255.
11. 11C]β-CIT binding to monoamine transporters in the monkey and human brain. Synapse 1994; 16: 93-103.
12. 123I]β-CIT, a tracer for dopamine reuptake sites, preparation and preliminary SPET studies in humans. J Nucl Biol Med 1994; 38 Suppl 1-4: 128-131.
13. Tiihonen J, Kuikka J, Bergström K, et al. Altered striatal dopamine re-uptake site densities in habitually violent and nonviolent alcoholics. Nature Med 1995; 1: 654-657.
14. Kuikka JT, Tiihonen J, Bergström KA, et al. Imaging of serotonin and dopamine transporters in the living human brain. Eur J Nucl Med 1995; 22: 346-350.
15. 3H]paroxetine binding to serotonin uptake sites in human brain tissue. Brain Res 1989; 486: 261-268.
16. 3H]citalopram as markers of the human brain 5-HT uptake site: a comparison study. J Neural Transm Gen Sect 1994; 97: 27-40.
17. Boja JW, Kuhar MJ, Kopajtic T, et al. Secondary amine analogues of 3β-(4′-substituted phenyl)tropane-2β-carboxylic acid esters and N-norcocaine exhibit enhanced affinity for serotonin and norepinephrine transporters. J Med Chem 1994; 37: 1220-1223.
18. 3H]mazindol autoradiogruphy. J Comp Neurol 1991; 304: 419-434.
19. 3H]desipramine-binding sites in human postmortem brain tissue. Neuropsychobiology 1990; 23: 68-73.
20. 125I-labelled β-CIT and its ω-fluoroalkyl analogues β-CIT-FE and β-CIT-FP including the synthesis of precursors. J Label Cmpds Radiopharm 1996; 38: 675-685.
21. 18F-labelled analogues of β-CIT. Labelling in different positions and PET evaluation in Cynomolgus monkeys. J Label Cmpds Radiopharm 1995; 37: 52-54.
22. 2-dopamine receptors, and dopamine and its metabolites in the human brain. Neuropsychopharmacology 1994; 11: 245-256.
23. 125I]epidepride. Synapse 1996; 23: 115-123.
24. 11C-Ro 15-1788 binding to human brain sections. J Neurosci Methods 1991; 36: 53-61.
25. Hyttel J, Citalopram: pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity. Prog Neuropsychopharmacol Biol Psychiatry 1982; 6: 277-295.
26. Andersen PH. The dopamine uptake inhibitor GBR 12909: selectivity and molecular mechanisms of action. Eur J Pharmacol 1989; 166: 493-504.
27. Weinhard K, Dahlbom M, Eriksson L, et al. The ECAT EXACT HR: performance of a new high resolution positron scanner. J Comput Assist Tomogr 1994; 18: 110-118.
28. 1-dopamine receptor. Psychopharmacology 1993; 113: 149-156.
29. Halldin C, Swahn C-G, Farde L, Sedvall G. Radioligand disposition and metabolism - key information in early drug development. In: Comar D, ed. PET for drug development and evaluation. Dordrecht: Kluwer; 1995: 55-65.
30. 123I]β-CIT in human plasma may obstruct quantitation of the dopamine transporter. Synapse 1995; 19: 297-300.
31. Bergström KA, Halldin C, Lundkvist C. et al. Characterization of C-11 or I-123 labelled β-CIT-FP and β-CIT-FE metabolism in monkey and human plasma. Identification of two labelled metabolites with HPLC. Hum Psychopharmacol 1996; 11: 483-490.
32. 11C]SCH 23390. Identification of two radiolabelled metabolites with HPLC. Hum Psychopharmacol 1994; 9: 25-31.
33. 3H]GBR-12935 binding to dopamine uptake sites in the human brain. Brain Res 1988; 457: 122-129.
34. 125I]β-CIT-FP binding in the human brain. Nucl Med Biol (in press)
35. 11]cocaine binding to decreases in synaptic dopamine. Synapse 1995; 20: 137-144.
36. Dray A, Davies J, Oakley N, Tongroach P, Vellucci S. The dorsal and medial raphe projrections to the substantia nigra in the rat: electrophysical, biochemical and behavioral observations. Brain Res 1978; 151: 431-442.
37. Spampinato U, Esposito E, Samanin R, Serotonergic agonists reduce dopamine synthesis in the striatum only when the impulse flow of nigrostriatal neurons is intact. J Neurochem 1985; 980-982.
38. 2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition. Psychopharmacology 1989; 98: 45-50.
39. Dewey SL, Smith GS, Logan J, et al. Serotonergic modulation of striatal dopamine measured with positron emission tomography and in vivo microdiatysis. J Neurosci 1995; 15: 821-829.
40. Suehiro M, Scheffel U, Dannals RF, Ravert HT, Ricaurte GA, Wagner HN Jr. A PET radiotracer for studying serotonin uptake sites: carbon-11-McN-5652Z. J Nucl Med 1993; 34: 120-127.
41. Mazière B, Mazière M. Studying in vivo brain chemistry with SPECT: receptors and neurotransmission. In: Costa DC, Morgan GF, Lassen NA. eds. New trends in nculear neurology and psychiatry. London: John Libbey; 1993: 85-100.
42. 123I]5-iodo-6-nitroquipazin. Eur J Pharmacol 1993; 242: 189-193.
43. 11C](+)McN5652. Synapse 1995; 20: 37-43.
44. Jagust WJ, Eberlin JL, Biegon A, et al. Iodine-123-5-iodo-6-nitroquipazine: SPECT radiotracer to image the serotonin transporter. J Nucl Med 1996; 37: 1207-1214.
45. Misra AL, Pontani RB, Vadlamani NL. Metabolism of norcocaine, N-hydroxy norcocaine and cocaine-N-oxide in the rat. Xenobiotica 1979; 9: 189-199.
46. Jindal SP, Lutz T. Ion cluster techniques in drug metabolism: use of a mixture of labeled and unlabeled cocaine to facilitate metabolite identification. J Anal Toxicol 1986; 10: 150-155.